HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects

Clinical trial NCT06520540 · UNKNOWN

Trial details

NCT number: NCT06520540
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Glucagon-Like Peptide-1 Receptor Agonists

Start date: 2024-07-28
Primary completion: 2024-11-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.